Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Director departure
Appointed director
Vanda Pharmaceuticals Inc. (VNDA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 8-K Other Events  Interactive Data
07/27/2023 8-K Quarterly results
Docs: "Vanda Pharmaceuticals Reports Second Quarter 2023 Financial Results"
06/08/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/11/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Corporate Contact:"
03/17/2023 8-K Appointed a new director
Docs: "Vanda Pharmaceuticals Appoints Dr. Tage"
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
02/08/2023 8-K Quarterly results
12/22/2022 8-K Other Events  Interactive Data
12/16/2022 8-K Quarterly results
12/14/2022 8-K Quarterly results
11/02/2022 8-K Quarterly results
08/03/2022 8-K Quarterly results
Docs: "Vanda Pharmaceuticals Reports Second Quarter 2022 Financial Results"
06/16/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
03/01/2022 8-K Quarterly results
02/23/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results"
02/04/2022 8-K Quarterly results
01/14/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Vanda Pharmaceuticals Settles HETLIOZ ® Patent Litigation with MSN"
11/03/2021 8-K Quarterly results
Docs: "Vanda Pharmaceuticals Reports Third Quarter 2021 Financial Results"
10/08/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/28/2021 8-K Quarterly results
Docs: "Vanda Pharmaceuticals Reports Second Quarter 2021 Financial Results"
06/10/2021 8-K Quarterly results
05/05/2021 8-K Quarterly results
02/25/2021 8-K Quarterly results
02/10/2021 8-K Quarterly results
12/02/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "FDA Approves HETLIOZ ® for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome"
10/28/2020 8-K Quarterly results
Docs: "Vanda Pharmaceuticals Reports Third Quarter 2020 Financial Results"
08/18/2020 8-K Quarterly results
08/05/2020 8-K Quarterly results
07/29/2020 8-K Quarterly results
06/11/2020 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/26/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Vanda Pharmaceuticals Announces Virtual 2020 Stockholder Meeting"
05/13/2020 8-K Quarterly results
05/06/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy